Solution
Industries
Resources
About
  1. Press Releases
  2. 2010
  3. Pharmaceuticals

Drug-Device Combinations: The Global Market

March 05, 2010

 

Wellesley, Mass. – According to a new technical market research report, DRUG-DEVICE COMBINATIONS: THE GLOBAL MARKET (PHM045B) from BCC Research (www.bccresearch.com), the global market for drug-device combinations was valued at an estimated $13.7 billion in 2009, and is expected to increase to $27 billion by the end of 2014, for a compound annual growth rate (CAGR) of 14.5%.
 
The coronary stents segment has the largest share of the market at $4.8 billion in 2009, and is expected to increase by 2014 to $7.4 billion, for a CAGR of 9%.
 
The photodynamics therapy segment was valued at about $1.5 billion in 2009, and is expected to rise to $2.6 billion in 2014, for a CAGR of 11.6%.
 
The antimicrobial catheters segment is projected to be worth $2.2 billion in 2014, after growing at a CAGR of 11.1% from its 2009 value of $1.3 billion.
 
The orthopedic applications segment was worth an estimated $1.2 billion in 2009, and is expected to reach $1.8 billion in 2014, for a CAGR of 8.4%
 

SUMMARY FIGURE
SALES OF DRUG DEVICE COMBINATION PRODUCTS, 2008-2014
($ BILLIONS)
SALES OF DRUG DEVICE COMBINATION PRODUCTS, 2008-2014
To Contact us, click here  help


Source: BCC Research
 
Combination products are therapeutic and, in some cases, diagnostic products that combine elements of drugs, devices, and/or biological products. This report mainly covers devices that serve a therapeutic function and have a drug component incorporated into them. The study provides an overview of the current drug-device combination product market and an insight into the emerging market segments, which are sizable in the case of this industry.
 
The combination product sector includes drug-eluting stents, drug-eluting beads, antimicrobial catheters, antibiotic-loaded bone cements, glass ionomer cements, bone graft substitutes, antibacterial-releasing dental restorative materials, biologic wound-care products such as collagen-based dressings as therapeutic agents for wound healing, drug device combination products for ocular applications, photodynamic therapy, and other important niches.
 

This study will be particularly useful for researchers, laboratory and government personnel working in research or company settings, as well as business professionals involved with drug and device development. It also will be of value to potential investors and members of the general public interested in acquiring a business-oriented view of a key healthcare sector in the economy.

Drug-device Combinations: The Global Market( PHM045B )
Publish Date: Jan 2010    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.

BCC Library Membership Benefits

Unlimited Access to Market Research Reports for Academic Institutions and Corporations.

Custom Research

Tailored solutions across industries for your unique business needs.

Drug-device Combinations: The Global Market
Customize This Report

More in Pharmaceuticals

Reports from Pharmaceuticals

Recent News

Browse by Year

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2026 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment